167 related articles for article (PubMed ID: 7706942)
1. Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism.
Packard CJ; Gaw A; Demant T; Shepherd J
J Lipid Res; 1995 Jan; 36(1):172-87. PubMed ID: 7706942
[TBL] [Abstract][Full Text] [Related]
2. Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins.
Gaw A; Packard CJ; Lindsay GM; Griffin BA; Caslake MJ; Lorimer AR; Shepherd J
J Lipid Res; 1995 Jan; 36(1):158-71. PubMed ID: 7706941
[TBL] [Abstract][Full Text] [Related]
3. Model development to describe the heterogeneous kinetics of apolipoprotein B and triglyceride in hypertriglyceridemic subjects.
Barrett PH; Baker N; Nestel PJ
J Lipid Res; 1991 May; 32(5):743-62. PubMed ID: 2072038
[TBL] [Abstract][Full Text] [Related]
4. Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.
Taskinen MR; Packard CJ; Shepherd J
Diabetes; 1990 Sep; 39(9):1017-27. PubMed ID: 2200727
[TBL] [Abstract][Full Text] [Related]
5. Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes.
Vergès B; Florentin E; Baillot-Rudoni S; Monier S; Petit JM; Rageot D; Gambert P; Duvillard L
Diabetologia; 2008 Aug; 51(8):1382-90. PubMed ID: 18535816
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia.
Demant T; Gaw A; Watts GF; Durrington P; Buckley B; Imrie CW; Wilson C; Packard CJ; Shepherd J
J Lipid Res; 1993 Jan; 34(1):147-56. PubMed ID: 8445339
[TBL] [Abstract][Full Text] [Related]
7. Effects of simvastatin on apoB metabolism and LDL subfraction distribution.
Gaw A; Packard CJ; Murray EF; Lindsay GM; Griffin BA; Caslake MJ; Vallance BD; Lorimer AR; Shepherd J
Arterioscler Thromb; 1993 Feb; 13(2):170-89. PubMed ID: 8427854
[TBL] [Abstract][Full Text] [Related]
8. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans.
Anber V; Millar JS; McConnell M; Shepherd J; Packard CJ
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2507-14. PubMed ID: 9409221
[TBL] [Abstract][Full Text] [Related]
9. Studies on the metabolism of apolipoprotein B in hypertriglyceridemic subjects using simultaneous administration of tritiated leucine and radioiodinated very low density lipoprotein.
Beltz WF; Kesäniemi YA; Miller NH; Fisher WR; Grundy SM; Zech LA
J Lipid Res; 1990 Mar; 31(3):361-74. PubMed ID: 2341804
[TBL] [Abstract][Full Text] [Related]
10. Effects of 1,2-cyclohexanedione modification on the metabolism of very low density lipoprotein apolipoprotein B: potential role of receptors in intermediate density lipoprotein catabolism.
Packard CJ; Boag DE; Clegg R; Bedford D; Shepherd J
J Lipid Res; 1985 Sep; 26(9):1058-67. PubMed ID: 4067428
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein.
Sattar N; Greer IA; Louden J; Lindsay G; McConnell M; Shepherd J; Packard CJ
J Clin Endocrinol Metab; 1997 Aug; 82(8):2483-91. PubMed ID: 9253322
[TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins.
Bradley WA; Hwang SL; Karlin JB; Lin AH; Prasad SC; Gotto AM; Gianturco SH
J Biol Chem; 1984 Dec; 259(23):14728-35. PubMed ID: 6501314
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria.
Warwick GL; Packard CJ; Demant T; Bedford DK; Boulton-Jones JM; Shepherd J
Kidney Int; 1991 Jul; 40(1):129-38. PubMed ID: 1921148
[TBL] [Abstract][Full Text] [Related]
14. The metabolism of apolipoprotein B in subjects with hypertriglyceridemia and polydisperse LDL.
Fisher WR; Zech LA; Bardalaye P; Warmke G; Berman M
J Lipid Res; 1980 Aug; 21(6):760-74. PubMed ID: 7419987
[TBL] [Abstract][Full Text] [Related]
15. Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins.
Beltz WF; Kesäniemi YA; Howard BV; Grundy SM
J Clin Invest; 1985 Aug; 76(2):575-85. PubMed ID: 4031063
[TBL] [Abstract][Full Text] [Related]
16. Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men.
Millar JS; Lichtenstein AH; Cuchel M; Dolnikowski GG; Hachey DL; Cohn JS; Schaefer EJ
J Lipid Res; 1995 Jun; 36(6):1155-67. PubMed ID: 7665994
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions.
Packard CJ; Demant T; Stewart JP; Bedford D; Caslake MJ; Schwertfeger G; Bedynek A; Shepherd J; Seidel D
J Lipid Res; 2000 Feb; 41(2):305-18. PubMed ID: 10681415
[TBL] [Abstract][Full Text] [Related]
18. Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects.
Berman M; Hall M; Levy RI; Eisenberg S; Bilheimer DW; Phair RD; Goebel RH
J Lipid Res; 1978 Jan; 19(1):38-56. PubMed ID: 202659
[TBL] [Abstract][Full Text] [Related]
19. In vivo studies of VLDL metabolism and LDL heterogeneity.
Demant T; Packard C
Eur Heart J; 1998 Jul; 19 Suppl H():H7-10. PubMed ID: 9717058
[TBL] [Abstract][Full Text] [Related]
20. Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
Taskinen MR; Björnson E; Kahri J; Söderlund S; Matikainen N; Porthan K; Ainola M; Hakkarainen A; Lundbom N; Fermanelli V; Fuchs J; Thorsell A; Kronenberg F; Andersson L; Adiels M; Packard CJ; Borén J
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):962-975. PubMed ID: 33356392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
